(Q50919276)

25 March 2018

title

"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. (English)

1 reference

25 March 2018

1 reference

1

1 reference

25 March 2018

Giacoma Di Vieste

4

object named as

Giacoma Di Vieste

1 reference

25 March 2018

author name string

Valentina Donato

2

1 reference

25 March 2018

Basilio Pintaudi

3

1 reference

25 March 2018

Valeria Chirico

5

1 reference

25 March 2018

Antoine Buemi

6

1 reference

25 March 2018

Antonino Di Benedetto

7

1 reference

25 March 2018

Adriana Arena

8

1 reference

25 March 2018

Michele Buemi

9

1 reference

25 March 2018

publication date

11 June 2013

1 reference

25 March 2018

published in

Acta Diabetologica

1 reference

25 March 2018

volume

50

1 reference

25 March 2018

issue

6

1 reference

25 March 2018

page(s)

935-942

1 reference

25 March 2018

Histopathology of diabetic nephropathy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Nonalbuminuric renal insufficiency in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Tubular changes in early diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Extracellular matrix metabolism in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Aldose reductase and the role of the polyol pathway in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

A discovery-phase urine proteomics investigation in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

The role of renal proximal tubular cells in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

The use of myeloperoxidase as a risk marker for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Uric acid: bystander or culprit in hypertension and progressive renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0485-7

10.1007/S00592-013-0485-7

21 January 2018

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018